<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03143452</url>
  </required_header>
  <id_info>
    <org_study_id>IndonesiaUAnes015</org_study_id>
    <nct_id>NCT03143452</nct_id>
  </id_info>
  <brief_title>Comparison Between 2% Lidocaine Gel and 5% Tetracaine Eye Drop as Topical Anesthesia in Phacoemulsification</brief_title>
  <official_title>Comparison Between 2% Lidocaine Gel and 5% Tetracaine Eye Drop as Topical Anesthesia in Phacoemulsification</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to compare the efficacy between 2% lidocaine gel vs 0.5% tetracaine eye drop
      as topical anesthesia in phacoemulsification
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approval from Ethical Committee of Faculty of Medicine Universitas Indonesia was acquired
      prior conducting the study. Subjects were given informed consent before enrolling the study
      and randomized into two groups (Lidocaine gel and tetracaine eye drop group). Lidocaine group
      received 2% lidocaine gel in 1 ml syringe, applied to the eye. Tetracaine group received 0.5%
      tetracaine eye drop. Topical anesthesia was given 5 minutes before phacoemulsification. Five
      minutes after phacoemulsification finished, visual analog score (VAS) and subjects and
      surgeon's satisfaction were assessed. Every additional topical anesthesia needed was
      recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2016</start_date>
  <completion_date type="Actual">January 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog scale</measure>
    <time_frame>Day 1</time_frame>
    <description>assessing subject's pain with visual analog scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Additional topical anesthesia requirement</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of additional topical anesthesia given after the first dose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjects and surgeon's satisfactory</measure>
    <time_frame>Day 1</time_frame>
    <description>Assessment is done using questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Adult Patients Undergoing Phacoemulsification With Topical Anesthesia</condition>
  <arm_group>
    <arm_group_label>lidocaine gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lidocaine gel group: received 2% lidocaine gel in 1 ml syringe, applied to the eye 5 minutes before phacoemulsification</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tetracaine eye drop</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tetracaine eye drop group: received 0.5% tetracaine eye drop 5 minutes before phacoemulsification</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine gel</intervention_name>
    <description>2% lidocaine gel in 1 ml syringe, applied to the eye 5 minutes before phacoemulsification</description>
    <arm_group_label>lidocaine gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tetracaine eye drop</intervention_name>
    <description>0.5% tetracaine eye drop was given 5 minutes before phacoemulsification</description>
    <arm_group_label>tetracaine eye drop</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients aged more than 40 years old who were planned to undergo elective
             phacoemulsification with intraocular lens implantation at operating room. The surgery
             was operated by an experienced ophthalmologist. Subjects had been explained about the
             study, and agreed to enroll and have signed the informed consent form.

        Exclusion Criteria:

          -  Subjects with history of allergy to topical anesthesia (2% lidocaine gel and 0.5%
             tetracaine eye drop), subjects who used another method of intraoperative anesthesia
             other than topical anesthesia, subjects with history of phacoemulsification before,
             subjects with difficulty in communication, dementia, and anxiety.

        Dropout Criteria:

          -  Phacoemulsifications duration more than 30 minutes, and subjects who resigned from the
             study before the study ended
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cipto Mangunkusumo Central National Hospital</name>
      <address>
        <city>Jakarta</city>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <reference>
    <citation>Jinapriya D, Almeida DR, Johnson D, Irrcher I, El-Defrawy SR. Anaesthetic plus dilating gel improves pupil dilation for cataract surgery. Can J Ophthalmol. 2012 Apr;47(2):145-9. doi: 10.1016/j.jcjo.2012.01.007. Epub 2012 Mar 14.</citation>
    <PMID>22560419</PMID>
  </reference>
  <reference>
    <citation>Tsoumani AT, Asproudis IC, Damigos D. Tetracaine 0.5% eyedrops with or without lidocaine 2% gel in topical anesthesia for cataract surgery. Clin Ophthalmol. 2010 Sep 7;4:967-70.</citation>
    <PMID>20856590</PMID>
  </reference>
  <reference>
    <citation>Waheeb S. Topical anesthesia in phacoemulsification. Oman J Ophthalmol. 2010 Sep;3(3):136-9. doi: 10.4103/0974-620X.71892.</citation>
    <PMID>21120050</PMID>
  </reference>
  <reference>
    <citation>Chalam KV, Murthy RK, Agarwal S, Gupta SK, Grover S. Comparative efficacy of topical tetraVisc versus lidocaine gel in cataract surgery. BMC Ophthalmol. 2009 Aug 17;9:7. doi: 10.1186/1471-2415-9-7.</citation>
    <PMID>19686592</PMID>
  </reference>
  <reference>
    <citation>Shiroma HF, Shimono KE, Farah ME, Goldhardt R, Grumann A Jr, Rodrigues EB. Comparative Study Between Lidocaine Gel 2% and 5% for Ophthalmic Procedures. J Ocul Pharmacol Ther. 2016 May;32(4):192-5. doi: 10.1089/jop.2015.0002. Epub 2016 Jan 20.</citation>
    <PMID>26790036</PMID>
  </reference>
  <reference>
    <citation>Rafailov L, Kulak A, Weedon J, Shinder R. Comparison of Lidocaine Gel-Assisted Transconjunctival and Transcutaneous Local Anesthesia for Outpatient Eyelid Surgery. Ophthalmic Plast Reconstr Surg. 2015 Nov-Dec;31(6):470-3. doi: 10.1097/IOP.0000000000000391.</citation>
    <PMID>25675169</PMID>
  </reference>
  <reference>
    <citation>Soliman MM, Macky TA, Samir MK. Comparative clinical trial of topical anesthetic agents in cataract surgery: lidocaine 2% gel, bupivacaine 0.5% drops, and benoxinate 0.4% drops. J Cataract Refract Surg. 2004 Aug;30(8):1716-20.</citation>
    <PMID>15313296</PMID>
  </reference>
  <reference>
    <citation>Shah H, Reichel E, Busbee B. A novel lidocaine hydrochloride ophthalmic gel for topical ocular anesthesia. Local Reg Anesth. 2010;3:57-63. Epub 2010 Aug 10.</citation>
    <PMID>22915870</PMID>
  </reference>
  <reference>
    <citation>Amiel H, Koch PS. Tetracaine hydrochloride 0.5% versus lidocaine 2% jelly as a topical anesthetic agent in cataract surgery: comparative clinical trial. J Cataract Refract Surg. 2007 Jan;33(1):98-100.</citation>
    <PMID>17189801</PMID>
  </reference>
  <reference>
    <citation>Irle S, LÃ¼ckefahr MH, Tho Seeth T. [Tetracaine drops versus lidocaine gel for topical anaesthesia in cataract surgery]. Klin Monbl Augenheilkd. 2003 Sep;220(9):625-8. German.</citation>
    <PMID>14533061</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2017</study_first_submitted>
  <study_first_submitted_qc>May 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2017</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Susilo Chandra</investigator_full_name>
    <investigator_title>Anesthesiologist Consultant</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Tetracaine</mesh_term>
    <mesh_term>Tetrahydrozoline</mesh_term>
    <mesh_term>Ophthalmic Solutions</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

